Skip to main content
SpringerLink
Log in

Single and Repeated GnRH Agonist Stimulation Tests Compared With Basal Markers of Ovarian Reserve in the Prediction of Outcome in IVF

  • Assisted Reproduction
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Purpose: To study the value of a single or repeated GnRH agonist stimulation test (GAST) in predicting outcome in IVF compared to basal ovarian reserve tests.

Methods: A total of 57 women was included. In a cycle prior to the IVF treatment, on day 3, an antral follicle count (AFC) was performed and blood taken for basal FSH, inhibin B and E2 measurements, followed by a subcutaneous injection of 100 μg triptorelin for the purpose of the GAST. Twenty-four hours later blood sampling was repeated. All the tests were repeated in a subsequent cycle. From the GAST E2 and inhibin B response were used as test parameters. The outcome measures were poor ovarian response and ongoing pregnancy. Group comparisons were done using the Mann– Whitney or chi-square test. Univariate and multivariate logistic regression was applied to assess which test revealed the highest predictive accuracy as expressed in the area under receiver-operating characteristic curve (ROCAUC). Clinical value was compared by calculating classical test characteristics for the best logistic models.

Results: All the basal and GAST variables were significantly different in the poor responders (n = 19) compared to normal responders (n = 38). In the univariate analysis on cycle 1 tests the AFC was the best predictor for poor ovarian response, while in cycle 2 the E2 response in the GAST performed best (ROCAUC of 0.91 for both). Multivariate analysis of the basal variables led to the selection of AFC and inhibin B in cycle 1, yielding a ROCAUC of 0.96. Mean E2 response was selected in a multivariate analysis of the repeated GAST variables (ROCAUC 0.91). At a specificity level of ∼0.90, several logistic models including GAST variables appeared to have a sensitivity (∼0.80), positive predictive value (∼0.82) and false positive rate (∼0.18), comparable to a logistic model containing AFC and inhibin B. None of the test variables showed a significant relation with ongoing pregnancy.

Conclusions: The GAST has a rather good ability to predict poor response in IVF. However, comparing the predictive accuracy and clinical value of the GAST with a day 3 AFC and inhibin B, it appeared that neither a single nor a repeated GAST performed better. In addition, the predictive ability towards ongoing pregnancy is poor. Therefore, the use of the GAST as a predictor of outcome in IVF should not be advocated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. te Velde ER, Pearson PL: The variability of female reproductive ageing. Hum Reprod Update 2002;8:141– 154

    Google Scholar 

  2. Toner JP, Philput CB, Jones GS, Muasher SJ: Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age. Fertil Steril 1991;55:784– 791

    Google Scholar 

  3. Bancsi LF, Huijs AM, den Ouden CT, Broekmans FJ, Looman CW, Blankenstein MA, te Velde ER: Basal follicle-stimulating hormone levels are of limited value in predicting ongoing pregnancy rates after in vitro fertilization. Fertil Steril 2000;73:552– 557

    Google Scholar 

  4. Bancsi LF, Broekmans FJ, Mol BW, Habbema JD, te Velde ER: Performance of basal follicle-stimulating hormone in the prediction of poor ovarian response and failure to become pregnant after in vitro fertilization: a meta-analysis. Fertil Steril 2003;79:1091– 1100

    Google Scholar 

  5. Loumaye E, Billion JM, Mine JM, Psalti I, Pensis M, Thomas K: Prediction of individual response to controlled ovarian hyperstimulation by means of a clomiphene citrate challenge test. Fertil Steril 1990;53:295– 301

    Google Scholar 

  6. Navot D, Rosenwaks Z, Margalioth EJ: Prognostic assessment of female fecundity. Lancet 1987;2:645– 647

    Article  Google Scholar 

  7. Scott RT, Leonardi MR, Hofmann GE, Illions EH, Neal GS, Navot D: A prospective evaluation of clomiphene citrate challenge test screening of the general infertility population. Obstet Gynecol 1993;82:539– 544

    Google Scholar 

  8. Winslow KL, Toner JP, Brzyski RG, Oehninger SC, Acosta AA, Muasher SJ: The gonadotropin-releasing hormone agonist stimulation test— A sensitive predictor of performance in the flare-up in vitro fertilization cycle. Fertil Steril 1991;56:711– 717

    Google Scholar 

  9. Fanchin R, de Ziegler D, Olivennes F, Taieb J, Dzik A, Frydman R: Exogenous follicle stimulating hormone ovarian reserve test (EFORT): A simple and reliable screening test for detecting ‘poor responders’ in in-vitro fertilization. Hum Reprod 1994;9:1607– 1611

    Google Scholar 

  10. Hall JE, Welt CK, Cramer DW: Inhibin A and inhibin B reflect ovarian function in assisted reproduction but are less useful at predicting outcome. Hum Reprod 1999;14:409– 415

    Article  Google Scholar 

  11. Seifer DB, MacLaughlin DT, Christian BP, Feng B, Shelden RM: Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril 2002;77:468– 471

    Google Scholar 

  12. Van Rooij IA, Broekmans FJ, te Velde ER, Fauser BC, Bancsi LF, de Jong FH, Themmen AP: Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve. Hum Reprod 2002;17:3065– 3071

    Google Scholar 

  13. Chang MY, Chiang CH, Hsieh TT, Soong Yk, Hsu KH: Use of the antral follicle count to predict the outcome of assisted reproductive technologies. Fertil Steril 1998;69:505– 510

    Article  Google Scholar 

  14. Tomas C, Nuojua-Huttunen S, Martikainen H: Pretreatment transvaginal ultrasound examination predicts ovarian responsiveness to gonadotrophins in in-vitro fertilization. Hum Reprod 1997;12:220– 223

    Google Scholar 

  15. Bancsi LF, Broekmans FJ, Eijkemans MJ, de Jong FH, Habbema JD, te Velde ER: Predictors of poor ovarian response in in vitro fertilization: A prospective study comparing basal markers of ovarian reserve. Fertil Steril 2002;77:328– 336

    Article  Google Scholar 

  16. Avrech OM, Royburt M, Sabah G, Zukerman Z, Pinkas H, Amit S, Ovadia J, Fisch B: The initial flare-up induced by gonadotropin releasing hormone agonist may serve as a predictor of ovarian response in the current IVF-ET treatment cycle in normogonadotropic women aged 40– 48 years. J Assist Reprod Genet 1996;13:395– 400

    Google Scholar 

  17. Dzik A, Lambert-Messerlian G, Izzo VM, Soares JB, Pinotti JA, Seifer DB: Inhibin B response to EFORT is associated with the outcome of oocyte retrieval in the subsequent in vitro fertilization cycle. Fertil Steril 2000;74:1114– 1117

    Google Scholar 

  18. Eldar-Geva T, Margalioth EJ, Ben Chetrit A, Gal M, Robertson DM, Healy DL, Diamant YZ, Spitz IM: Serum inhibin B levels measured early during FSH administration for IVF may be of value in predicting the number of oocytes to be retrieved in normal and low responders. Hum Reprod 2002;17:2331– 2337

    Google Scholar 

  19. Elting MW, Kwee J, Schats R, Rekers-Mombarg LT, Schoemaker J: The rise of estradiol and inhibin B after acute stimulation with follicle-stimulating hormone predict the follicle cohort size in women with polycystic ovary syndrome, regularly menstruating women with polycystic ovaries, and regularly menstruating women with normal ovaries. J Clin Endocrinol Metab 2001;86:1589– 1595

    Google Scholar 

  20. Galtier-Dereure F, De Bouard V, Picto MC, Vergnes C, Humeau C, Bringer J, Hedon B: Ovarian reserve test with the gonadotrophin-releasing hormone agonist buserelin: Correlation with in-vitro fertilization outcome. Hum Reprod 1996;11:1393– 1398

    Google Scholar 

  21. Ranieri DM, Quinn F, Makhlouf A, Khadum I, Ghutmi W, McGarrigle H, Davies M, Serhal P: Simultaneous evaluation of basal follicle-stimulating hormone and 17 beta-estradiol response to gonadotropin-releasing hormone analogue stimulation: an improved predictor of ovarian reserve. Fertil Steril 1998;70:227– 233

    Google Scholar 

  22. Ravhon A, Lavery S, Michael S, Donaldson M, Margara R, Trew G, Winston R: Dynamic assays of inhibin B and oestradiol following buserelin acetate administration as predictors of ovarian response in IVF. Hum Reprod 2000;15:2297– 2301

    Google Scholar 

  23. Padilla SL, Bayati J, Garcia JE: Prognostic value of the early serum estradiol response to leuprolide acetate in in vitro fertilization. Fertil Steril 1990;53:288– 294

    Google Scholar 

  24. Bukman A, Heineman MJ: Ovarian reserve testing and the use of prognostic models in patients with subfertility. Hum Reprod Update 2001;7:581– 590

    Google Scholar 

  25. Broekmans FJ, Bernardus RE, Broeders A, Berkhout G, Schoemaker J: Pituitary responsiveness after administration of a GnRH agonist depot formulation: Decapeptyl CR. Clin Endocrinol (Oxf) 1993;38:579– 587

    Google Scholar 

  26. Groome NP, Illingworth PJ, O’Brien M, Pai R, Rodger FE, Mather JP, McNeilly AS: Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab 1996;81:1401– 1405

    Google Scholar 

  27. van Kooij RJ, Looman CW, Habbema JD, Dorland M, te Velde ER: Age-dependent decrease in embryo implantation rate after in vitro fertilization. Fertil Steril 1996;66:769– 775

    Google Scholar 

  28. Surrey ES, Bower J, Hill DM, Ramsey J, Surrey MW: Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization. Fertil Steril 1998;69:419– 424

    Google Scholar 

  29. El Toukhy T, Khalaf Y, Hart R, Taylor A, Braude P: Young age does not protect against the adverse effects of reduced ovarian reserve— An eight year study. Hum Reprod 2002;17:1519– 1524

    Google Scholar 

  30. Van Rooij IA, Bancsi LF, Broekmans FJ, Looman CW, Habbema JD, te Velde ER: Women older than 40 years of age and those with elevated follicle-stimulating hormone levels differ in poor response rate and embryo quality in in vitro fertilization. Fertil Steril 2003;79:482– 488

    Google Scholar 

  31. Moody Y (ed): Factors affecting the outcome in in vitro fertilization treatment. In Fertility Assessment and Treatment for People With Fertility Problems. Clinical Guideline 11, NHS., RCOG Press, London 2004, p 85

    Google Scholar 

  32. Bancsi LF, Broekmans FJ, Looman CW, Habbema JD, te Velde ER: Predicting poor ovarian response in IVF: use of repeat basal FSH measurement. J Reprod Med 2004;49:187– 194

    Google Scholar 

  33. Bancsi LF, Broekmans FJ, Looman CW, Habbema JD, te Velde ER: Impact of repeated antral follicle counts on the prediction of poor ovarian response in women undergoing in vitro fertilization. Fertil Steril 2004;81:35– 41

    Google Scholar 

  34. Gulekli B, Bulbul Y, Onvural A, Yorukoglu K, Posaci C, Demir N, Erten O: Accuracy of ovarian reserve tests. Hum Reprod 1999;14:2822– 2826

    Article  Google Scholar 

  35. Ozkaya O, Kaya H, Sezik M, Akyürek, Ozbasar D: The value of laboratory tests and ultrasonography in evaluating ovarian response to ovulation induction treatment with low-dose recombinant follicle-stimulating hormone. Int J Fertil Womens Med 2004;49:83– 87

    Google Scholar 

  36. Scheffer GJ, Broekmans FJ, Looman CW, Blankenstein M, Fauser BC, de Jong FH, te Velde ER: The number of antral follicles in normal women with proven fertility is the best reflection of reproductive age. Hum Reprod 2003;18:700– 706

    Google Scholar 

  37. Csemiczky G, Harlin J, Fried G: Predictive power of clomiphene citrate challenge test for failure of in vitro fertilization treatment. Acta Obstet Gynecol Scand 2002;81:954– 961

    Google Scholar 

  38. Tanbo T, Dale PO, Lunde O, Norman N, Abyholm T: Prediction of response to controlled ovarian hyperstimulation: A comparison of basal and clomiphene citrate-stimulated follicle-stimulating hormone levels. Fertil Steril 1992;57:819– 824

    Google Scholar 

  39. Lawson R, El Toukhy T, Kassab A, Taylor A, Braude P, Parsons J, Seed P: Poor response to ovulation induction is a stronger predictor of early menopause than elevated basal FSH: a life table analysis. Hum Reprod 2003;18:527– 533

    Google Scholar 

  40. Roest J, van Heusden AM, Mous H, Zeilmaker GH, Verhoeff A: The ovarian response as a predictor for successful in vitro fertilization treatment after the age of 40 years. FertilSteril1996;66:969– 973

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Reproductive Medicine, University Medical Centre Utrecht, Utrecht, The Netherlands

    D. J. Hendriks, F. J. Broekmans, L. F. J. M. M. Bancsi & E. R. te Velde

  2. Department of Public Health, Faculty of Medicine and Health Sciences, Erasmus University Rotterdam, Rotterdam, The Netherlands

    C. W. N. Looman

  3. Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands

    F. H. de Jong

Authors
  1. D. J. Hendriks
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. J. Broekmans
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. F. J. M. M. Bancsi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. W. N. Looman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. F. H. de Jong
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. E. R. te Velde
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. J. Hendriks.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hendriks, D.J., Broekmans, F.J., Bancsi, L.F.J.M.M. et al. Single and Repeated GnRH Agonist Stimulation Tests Compared With Basal Markers of Ovarian Reserve in the Prediction of Outcome in IVF. J Assist Reprod Genet 22, 65–74 (2005). https://doi.org/10.1007/s10815-005-1495-3

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10815-005-1495-3

Key words

Search

Navigation